Bioprocess automation refers to the use of advanced control systems, sensors, robotics and software to monitor, manage and optimize biological manufacturing processes. These processes include cell culture, fermentation, purification and formulation in the production of biopharmaceuticals, vaccines and other biotechnology products. The primary purpose of bioprocess automation is to enhance process efficiency, consistency and product quality while reducing human error and operational costs.
The bioprocess automation market consists of sales, by entities (organizations, sole traders, or partnerships), of bioprocess automation that is used whenever there is a need to control critical process parameters such as pH, temperature, dissolved oxygen and nutrient levels. It is commonly applied in cleanroom and Good Manufacturing Practices (GMP)-compliant manufacturing environments. The main complementary products to bioprocess automation include process analytical technologies (PAT), digital twin models and manufacturing execution systems (MES), while substitute products may include manual or semi-automated control systems.
The global bioprocess automation market was valued at $3,426.8 million in 2020 which grew till 2025 at a compound annual growth rate (CAGR) of more than 13.00%.
Growing Demand For Personalized Medicine
During the historic period, the bioprocess automation market was mainly driven by the growing demand for personalized medicine. This demand created a strong push for automation technologies that can support rapid changeovers, precise process control and scalability in smaller production runs. Automation platforms enabled manufacturers to reduce variability and ensure consistency across highly specialized therapies, laying the foundation for wider adoption of bioprocess automation. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based non-profit organization, the FDA approved a record 20 new personalized medicines, representing 38% of all new therapeutic molecular entities and marking the fourth consecutive year that personalized treatments accounted for more than a third of new drug approvals. This surge was especially significant in the rare disease category, with 16 personalized medicines approved for these conditions, more than doubling from just six approvals in 2022 and reflecting a major leap in addressing previously unmet medical needs in rare and often life-threatening genetic disorders. Therefore, the bioprocess automation market was mainly driven by the growing demand for personalized medicine.
Artificial Intelligence And Autonomous Intelligence
Major companies in the bioprocess automation market are increasingly prioritizing artificial intelligence and autonomous intelligence to enhance predictive bioprocess monitoring, automated decision-making, and real-time process optimization. These initiatives use machine learning algorithms, multimodal sensing technologies, and AI-driven analytics platforms. For example, in March 2026, the University of Nottingham, a UK-based research institution, launched BioSee AI, an artificial intelligence-enabled bioprocess monitoring platform that integrates ultrasonic and optical sensors with machine learning models to provide real-time insight into biological processes inside bioreactors without invasive probes, illustrating how artificial intelligence and autonomous intelligence are transforming predictive monitoring, process optimization, and intelligent control in modern bioprocess automation systems.
The global bioprocess automation market is fairly fragmented, with a large number of small players operating in the market. The top 10 competitors in the market made up 19.55% of the total market in 2024.
Bioprocess Automation Global Market Opportunities And Strategies To 2035 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global bioprocess automation market as it emerges from the COVID-19 shut down.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market research findings.
- Benchmark performance against key competitors.
- Utilize the relationships between key data sets for superior strategizing.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.
Where is the largest and fastest-growing market for bioprocess automation? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The bioprocess automation market global report from The Business Research Company answers all these questions and many more.
The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's history and forecasts market growth by geography. It places the market within the context of the wider bioprocess automation market; and compares it with other markets.
The report covers the following chapters
- Introduction and Market Characteristics - Brief introduction to the segmentations covered in the market, definitions and explanations about the segments, key products, supply chain and market attractiveness scoring and analysis.
- Key Trends - Highlights the major trends shaping the global market. This section also highlights likely future technologies and developments in the market.
- Growth Analysis And Strategic Analysis Framework - Analysis on PESTEL, end use industries, market growth rate, global historic (2020-2025) and forecast (2025-2030, 2035F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods, forecast growth contributors and total addressable market (TAM).
- Global Market Size And Growth: - Global historic (2020-2025) and forecast (2025-2030, 2035F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
- Regional And Country Analysis: - Historic (2020-2025) and forecast (2025-2030, 2035F) market values and growth and market share comparison by region and country.
- Market Segmentation: - Contains the market values (2020-2025) (2025-2030, 2035F) and analysis for each segment by component of process control system, by scale of operation, mode of operation and by compatibility with bioprocessing systems in the market. Historic (2020-2025) and forecast (2025-2030) and (2030-2035) market values and growth and market share comparison by region market.
- Regional Market Size And Growth: - Regional market size (2025), historic (2020-2025) and forecast (2025-2030, 2035F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
- Competitive Landscape: - Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players
- Other Major And Innovative Companies: - Details on the company profiles of other major and innovative companies in the market.
- Competitive Benchmarking: - Briefs on the financials comparison between major players in the market.
- Competitive Dashboard: - Briefs on competitive dashboard of major players.
- Key Mergers And Acquisitions: - Information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions, which have shaped the market in recent years.
- Recent Developments: - Information on recent developments in the market covered in the report.
- Market Opportunities And Strategies: Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
- Conclusions And Recommendations: This section includes recommendations for bioprocess automation providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
- Appendix: - This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.
Markets Covered:
- 1) By Component Of Process Control System: Sensors; Actuators; Controllers
- 2) By Scale Of Operation: Preclinical Operations, Clinical Operations; Commercial Operations
- 3) By Mode Of Operation: Batch; Fed-Batch; Perfusion
- 4) By Compatibility With Bioprocessing Systems: Single-Use Systems; Stainless Steel; Other Bioprocessing Systems
- Companies Mentioned: Thermo Fisher Scientific Inc.; Danaher Corporation (Cytia); Sartorius AG; Lonza Group AG; Merck KGaA (MilliporeSigma)
- Countries: China; Australia; India; Indonesia; Japan; South Korea; Taiwan; USA; Canada; Brazil; France; Germany; UK; Italy; Spain; Russia
- Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time-series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; bioprocess automation indicators comparison.
- Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.